Welcome to our Webinar page! We appreciate your interest in our scientific webinars and symposia. Our next webinar will examine pulmonary fibrosis in a preclinical context, with a focus on the mechanisms driving lung fibrosis and the role of machine learning in patient stratification, especially in COPD and other fibrotic pulmonary disorders. This event will take place on November 28, 2024. (11:00 AM – 12:30 PM EST / 17.00-18.30 CEST)
Join us for “Pulmonary Fibrosis in a Preclinical Context: Insights from Machine Learning and Translational Biomarkers,” to learn more about what drives pulmonary fibrosis, with insights from machine learning and translational biomarkers.
Agenda and speakers
Coming soon!
Scientific topics
The session will begin with an investigation into the mechanisms driving lung fibrosis, examining key processes that underlie this progressive condition. We will then delve into the role of machine learning in pulmonary research, highlighting its application for patient stratification and advanced analytics through a COPD case study.
Finally, discussions will focus on the use of translational biomarkers in drug development, offering insights into more targeted and effective therapies. This webinar is designed for researchers, clinicians, and industry professionals interested in the latest preclinical strategies for tackling pulmonary fibrosis.
Register nowThe ECM Pharmacology Symposium Series is a close collaboration with our industry sponsor Nordic Bioscience.